Intrauterine contraception: Incidence and factors associated with uterine perforationa population-based study

Human Reproduction

Volumn 27, Issue 9, 2012, Pages 2658-2663

  Kaislasuo, Janina ^a   Suhonen, Satu ^b   Gissler, Mika ^c,d   Lähteenmäki, Pekka ^a   Heikinheimo, Oskari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b City of Helsinki   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

Author keywords

contraception; incidence; IUD; IUS; perforation

Indexed keywords

LEVONORGESTREL;

ADULT; AMENORRHEA; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; INTRAUTERINE CONTRACEPTIVE DEVICE; LACTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; POPULATION BASED CASE CONTROL STUDY; PUERPERIUM; RANK SUM TEST; RETROSPECTIVE STUDY; UTERUS PERFORATION;

EID: 84864948670     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des246     Document Type: Article

References (25)

1. Andersson K, Mattson LK, Rybo G, Stadberg E. Intrauterine release of levonorgestrel-a new way of adding progestogen in hormone replacement therapy. Obstet Gynecol 1992;79:963-967.
2. Andersson K, Ryde-Blomqvist E, Lindell K, Odlind V, Milsom I. Perforations with intrauterine devices. Contraception 1998;57:251-255.
3. Boortz HE, Margolis DJA, Ragavendra N, Patel MK, Kadell BM. Migration of intrauterine devices: radiologic findings and implications for patient care. RadioGraphics 2012;32:335-352.
4. Caliskan E, Öztürk N, Dilbaz Ö, Dilbaz S. Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care 2003;8:150-155. (Pubitemid 37372408)
5. Chi IC, Potts M, Wilkens L, Champion CB. Performance of the TCu 380A device in breastfeeding and non-breastfeeding women. Contraception 1989;39:603-618. (Pubitemid 19148592)
6. Gemzell-Danielsson K, Inki P, Heikinheimo O. Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system. Acta Obstet Gynecol Scand 2011;90:1177-1188.
7. Harrison-Woolrych M, Ashton J, Coulter D. Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported? Contraception 2003;67:53-56. (Pubitemid 36084289)
8. Heartwell SF, Schlesselman S. Risk of uterine perforation among users of intrauterine devices. Obstet Gynecol 1983;61:31-36. (Pubitemid 13212371)
9. Heikinheimo O, Inki P, Kunz M, Parmhed S, Anttila AM, Olsson SE, Hurskainen R, Gemzell Danielsson K. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception 2010;81:481-486.
10. Heinemann K, Assmann A. European Active Surveillance Study for Intrauterine Devices (EURAS-IUD), 2012. http://www.clinicaltrials.gov (12 April 2012, date last accessed).
11. Heinemann K, Barnett C, Dinger JC. Intrauterine Devices and the Risk of Uterine Perforations: Interim Results from the EURAS-IUD Study [poster]. Tampa, FL: International Society for Pharmaceutical Engineering Congress, February 21-24, 2011.
12. International Classification of Diseases (ICD), World Health Organization (WHO). 2010. http://apps.who.int/classifications/icd10/browse/2010/en (12 April 2012, date last accessed).
13. Marchi NM, Castro S, Hidalgo MM, Hidalgo C, Monteiro-Dantas C, Villarroeal M, Bahamondes L. Management of missing strings in users of intrauterine contraceptives. Contraception 2012. [Epub ahead of print].
14. Millen A, Austin F, Bernstein GS. Analysis of 100 cases of missing IUD Strings. Contraception 1978;18:485-495. (Pubitemid 9032976)
15. National Institute for Health and Clinical Excellence (NICE). Guideline 30: long-acting reversible contraception, October 2005. http://www.nice.org.uk/ nicemedia/live/10974/29909/29909.pdf (12 April 2012, date last accessed).
16. Nordic Medico-Statistical Committee (NOMESCO). Classification of Surgical Procedures, version 1.15 2011 no. 93:2010 Copenhagen, 2010.
17. Sivin I, Stern J. International Committee for Contraceptive Research (ICCR). Health during prolonged use of levonorgestrel 20 microgram/ d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. Fertil Steril 1994;61:70-77. (Pubitemid 24030681)
18. Suhonen S, Haukkamaa M, Jakobsson T, Rauramo I. Clinical performance of a levonorgestrel releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 2004; 69:407-412. (Pubitemid 38510332)
19. Taloustutkimus. 2009. Taikuudesta nykyaikaisiin ehkä isymentelmiinehka ̈isyn historia. www.parempaaelamaa.fi/tiedotteet/ taikuudestanykyaikaisiin-ehkaeisymenetelmiin-ehkaeisyn-historia-ulottuu-kauas (12 April 2012, date last accessed).
20. van Grootheest K, Sachs B, Harrison Woolrych M, Caduff-Janosa P, van Puijenbroek E. Uterine perforation with the levonorgestrel-releasing Intrauterine device. Drug Saf 2011;34:83-88.
21. van Haudenhoven K, van Kaam KJAF, van Grootheest AC, Salemans THB, Dunselman GAJ. Uterine perforation in women using a levonorgestrelreleasing intrauterine system. Contraception 2006;73:257-260. (Pubitemid 43202176)
22. World Health Organisation (WHO). Medical Eligibility Criteria for Contraceptive Use, fourth edn, 2009. http://whqlibdoc.who.int/publications/2010/ 9789241563888-eng.pdf (12 April 2012, date last accessed).
23. Zakin D, Stern WZ, Rosenblatt R. Complete and partial uterine perforation and embedding following insertion of intrauterine devices I. Classification, complications, mechanism, incidence and missing strings. Obstet Gynecol Surv 1981a;36:335-353. (Pubitemid 11002400)
24. Zakin D, Stern WZ, Rosenblatt R. Complete and partial uterine perforation and embedding following insertion of intrauterine devices II. Diagnostic methods, prevention and management. Obstet Gynecol Surv 1981b;36:401-417. (Pubitemid 11006410)
25. Zouh L, Harrison-Woolrych M, Coulter D. Use of New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena). Pharmacoepidemiol Drug Saf 2003; 12:371-377. (Pubitemid 36903371)